Dabru I stated earlier that we should sell TAVR to interested people even at this early time. They might be those connected with 4C. We should retain 10% of the IP to placate the long suffering SHs. That way with perhaps selling the infusion business and raising 10 to 20m we could be on our way to profitability and with TGA and EU approvals we would be a profitable company with increasing earnings. Not floundering around at 10 to 15c.
Ann: Extension of Voluntary Suspension, page-56
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
-0.500(3.19%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.75 | $15.75 | $15.00 | $294.3K | 19.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1135 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.35 | 88 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |